{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T03:46:28Z","timestamp":1782704788305,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Taibah University Medical Sciences"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtumed.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:52:32Z","timestamp":1779385952000},"page":"542-547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world experience in the management of lipids in patients after an acute coronary syndrome"],"prefix":"10.1016","volume":"21","author":[{"given":"Omar","family":"Shariff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika","family":"Madhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Tennyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Bhagania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muqeet","family":"Enver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6186-3801","authenticated-orcid":false,"given":"Sunil K.","family":"Nadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.jtumed.2026.05.001_bib1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jtumed.2026.05.001_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13072043","article-title":"Lipid-lowering therapy after acute coronary syndrome","volume":"13","author":"Pogran","year":"2024","journal-title":"J Clin Med"},{"issue":"25","key":"10.1016\/j.jtumed.2026.05.001_bib3","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jtumed.2026.05.001_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.117.308903","article-title":"Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors","volume":"121","author":"Joseph","year":"2017","journal-title":"Circ Res"},{"issue":"9438","key":"10.1016\/j.jtumed.2026.05.001_bib5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jtumed.2026.05.001_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010075","article-title":"Lipids in atherosclerosis: pathophysiology and the role of calculated lipid indices in assessing cardiovascular risk in patients with hyperlipidemia","volume":"24","author":"Gaggini","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"9753","key":"10.1016\/j.jtumed.2026.05.001_bib7","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Cholesterol Treatment Trialists","year":"2010","journal-title":"Lancet"},{"issue":"10059","key":"10.1016\/j.jtumed.2026.05.001_bib8","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of Statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jtumed.2026.05.001_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13080916","article-title":"Appropriateness of dyslipidemia management strategies in post-acute coronary syndrome: a 2023 update","volume":"13","author":"Luca","year":"2023","journal-title":"Metabolites"},{"issue":"Suppl D","key":"10.1016\/j.jtumed.2026.05.001_bib10","doi-asserted-by":"crossref","first-page":"D312","DOI":"10.1093\/eurheartjsupp\/suad100","article-title":"ANMCO position paper on the management of hypercholesterolaemia in patients with acute coronary syndrome","volume":"25","author":"De Luca","year":"2023","journal-title":"Eur Heart J Suppl"},{"issue":"11","key":"10.1016\/j.jtumed.2026.05.001_bib11","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.jtumed.2026.05.001_bib12","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jtumed.2026.05.001_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.jtumed.2026.05.001_bib14","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"issue":"38","key":"10.1016\/j.jtumed.2026.05.001_bib15","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtumed.2026.05.001_bib16","series-title":"Cardiovascular disease: risk assessment and reduction, including lipid modification","author":"NifHaC","year":"2023"},{"key":"10.1016\/j.jtumed.2026.05.001_bib17","article-title":"Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study","volume":"29","author":"Ray","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"10.1016\/j.jtumed.2026.05.001_bib18","first-page":"30","article-title":"[Real-world efficacy of current lipid-lowering strategies in patients with acute coronary syndrome. Time to change the paradigm for treatment]","volume":"24","author":"Zuin","year":"2023","journal-title":"G Ital Cardiol"},{"key":"10.1016\/j.jtumed.2026.05.001_bib19","article-title":"Evaluating LDL-C control in Indian acute coronary syndrome (ACS) patients- A retrospective real-world study LDL-C control in ACS","volume":"19","author":"Jain","year":"2023","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"issue":"8","key":"10.1016\/j.jtumed.2026.05.001_bib20","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1080\/00325481.2022.2117498","article-title":"LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals","volume":"134","author":"Underberg","year":"2022","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.jtumed.2026.05.001_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jacl.2025.11.010","article-title":"From clinical inertia to therapeutic optimization in patients with atherosclerotic cardiovascular disease: a monte carlo simulation within the ITACARE-P registry","volume":"20","author":"Faggiano","year":"2026","journal-title":"J Clin Lipidol"},{"issue":"7","key":"10.1016\/j.jtumed.2026.05.001_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011765","article-title":"Patient-reported reasons for declining or discontinuing Statin therapy: insights from the PALM registry","volume":"8","author":"Bradley","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jtumed.2026.05.001_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S2213-8587(23)00316-9","article-title":"Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR outcomes randomised trial","volume":"12","author":"Ray","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.jtumed.2026.05.001_bib24","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1007\/s00392-022-02147-3","article-title":"Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (\"Jena auf Ziel\")","volume":"112","author":"Makhmudova","year":"2023","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"10.1016\/j.jtumed.2026.05.001_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2026.104543","article-title":"Low density lipoprotein target achivement in very high and extreme cardiovascular risk patients during a cardiac rehabilitation program","volume":"36","author":"Maloberti","year":"2026","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"11","key":"10.1016\/j.jtumed.2026.05.001_bib26","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.cjco.2025.06.021","article-title":"Implementing dyslipidemia guidelines into clinical practice following an acute coronary syndrome: challenges and opportunities for improvement","volume":"7","author":"Labinaz","year":"2025","journal-title":"CJC Open"},{"issue":"8","key":"10.1016\/j.jtumed.2026.05.001_bib27","article-title":"Intensive lipid-lowering therapy following acute coronary syndrome: the earlier the better","volume":"12","author":"Pradhan","year":"2025","journal-title":"J Cardiovasc Dev Dis"}],"container-title":["Journal of Taibah University Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361226000582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361226000582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T03:30:20Z","timestamp":1782703820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1658361226000582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1658361226000582"],"URL":"https:\/\/doi.org\/10.1016\/j.jtumed.2026.05.001","relation":{},"ISSN":["1658-3612"],"issn-type":[{"value":"1658-3612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world experience in the management of lipids in patients after an acute coronary syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Taibah University Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtumed.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}